Biomerica Inc. (BMRA) poses a Brand-New Opportunity for Investors with beta value of -0.72
Biomerica Inc. (NASDAQ: BMRA) started the day on June 10, 2021, with a price increase of 17.22% at $4.63. During the day, the stock rose to $5.05 and sunk to $3.83 before settling in for the price of $3.95 at the close. Taking a more long-term approach, BMRA posted a 52-week range of $3.30-$12.75.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 6.20%. Meanwhile, its Annual Earning per share during the time was -39.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 11.40%. This publicly-traded company’s shares outstanding now amounts to $11.91 million, simultaneously with a float of $10.19 million. The organization now has a market capitalization sitting at $56.07 million. At the time of writing, stock’s 50-day Moving Average stood at $4.33, while the 200-day Moving Average is $5.92.
If we measure the efficiency of the company that is accounted for 84 employees. It has generated 148,727 per worker during the last fiscal year. Meanwhile, its income per employee was -51,979. The stock had 4.16 Receivables turnover and 0.59 Total Asset turnover. For the Profitability, stocks gross margin was +26.62, operating margin was -35.90 and Pretax Margin of -34.84.
Biomerica Inc. (BMRA) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Diagnostics & Research Industry. Biomerica Inc.’s current insider ownership accounts for 11.10%, in contrast to 30.50% institutional ownership. According to the most recent insider trade that took place on Oct 26, this organization’s Director bought 9,100 shares at the rate of 5.45, making the entire transaction reach 49,595 in total value, affecting insider ownership by 9,100.
Biomerica Inc. (BMRA) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 2/27/2021, the organization reported -$0.15 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.08) by -$0.07. This company achieved a net margin of -34.95 while generating a return on equity of -25.71. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
Biomerica Inc.’s EPS increase for this current 12-month fiscal period is 11.40% and is forecasted to reach 0.20 in the upcoming year.
Biomerica Inc. (NASDAQ: BMRA) Trading Performance Indicators
Let’s observe the current performance indicators for Biomerica Inc. (BMRA). It’s Quick Ratio in the last reported quarter now stands at 5.90. The Stock has managed to achieve an average true range (ATR) of 0.33. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.30.
In the same vein, BMRA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.47, a figure that is expected to reach -0.08 in the next quarter, and analysts are predicting that it will be 0.20 at the market close of one year from today.
Technical Analysis of Biomerica Inc. (BMRA)
If we take a close look at the recent performances of Biomerica Inc. (NASDAQ: BMRA), its last 5-days Average volume was 0.46 million that shows progress from its year to date volume of 0.38 million. During the previous 9 days, stock’s Stochastic %D was recorded 86.67% While, its Average True Range was 0.33.
Raw Stochastic average of Biomerica Inc. (BMRA) in the period of the previous 100 days is set at 27.42%, which indicates a major fall in contrast to 74.23% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 75.70% that was higher than 73.62% volatility it exhibited in the past 100-days period.